Brunei Darussalam vs Europe (WHO region): Measles-containing-vaccine second-dose (MCV2) immunization coverage
Brunei Darussalam
99.0%
in 2025
Europe (WHO region)
89.0%
in 2025
Brunei Darussalam rank
1st
Europe (WHO region) rank
3rd
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Brunei Darussalam
- Europe (WHO region)
How they compare
Brunei Darussalam currently reports 99.0% against 89.0% in Europe (WHO region), a difference of 10.0%.
That makes Brunei Darussalam's figure about 1.1 times Europe (WHO region)'s.
Across all 26 years both countries report, Brunei Darussalam has been ahead every year.
Brunei Darussalam ranks 1st and Europe (WHO region) ranks 3rd of 194 countries.
Brunei Darussalam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.9% | 70.6% | 24.3% | Brunei Darussalam |
| 2010s | 95.8% | 87.3% | 8.5% | Brunei Darussalam |
| 2020s | 98.7% | 89.5% | 9.2% | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Brunei Darussalam or Europe (WHO region)?
- Brunei Darussalam, at 99.0% against 89.0% in Europe (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Brunei Darussalam and Europe (WHO region)?
- 10.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Europe (WHO region)?
- 26 years are reported by both, from 2000 to 2025.
- How do Brunei Darussalam and Europe (WHO region) rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Brunei Darussalam ranks 1st and Europe (WHO region) ranks 3rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.